His primary areas of investigation include Genetic enhancement, Adenoviridae, Cancer research, Molecular biology and Virology. His study on Genetic enhancement also encompasses disciplines like
His Cancer research research is multidisciplinary, incorporating perspectives in Cancer, Endocrinology, Cell culture, Apoptosis and Immunology. His work deals with themes such as Vector, Transfection, Reporter gene, Cell biology and In vivo, which intersect with Molecular biology. As part of his studies on Virology, David T. Curiel often connects relevant subjects like Transduction.
The scientist’s investigation covers issues in Genetic enhancement, Cancer research, Virology, Molecular biology and Adenoviridae. The Genetic enhancement study which covers Viral vector that intersects with Antigen. His Cancer research study which covers In vivo that intersects with In vitro.
His Molecular biology research incorporates elements of Reporter gene, Gene expression, Transfection, Receptor and Cell biology. He interconnects Infectivity and Genetic transfer in the investigation of issues within Adenoviridae. His research integrates issues of Vector and Computational biology in his study of Gene delivery.
David T. Curiel mainly investigates Cancer research, Virology, Genetic enhancement, Adenoviridae and Viral vector. His Cancer research study combines topics in areas such as Cancer cell, Cancer, Apoptosis and In vivo. The concepts of his Virology study are interwoven with issues in Epitope, Antibody and T cell.
His Genetic enhancement course of study focuses on Transgene and Gene targeting. His work carried out in the field of Adenoviridae brings together such families of science as Tropism, Cell culture, Viral replication, Molecular biology and Gene delivery. His Viral vector study integrates concerns from other disciplines, such as Vector, Computational biology and Antigen.
David T. Curiel mostly deals with Cancer research, Immunology, Apoptosis, Adenoviridae and Virology. His Cancer research study incorporates themes from Cancer cell, Genetic enhancement, Cytokine and Prostate cancer. His Immunology study combines topics from a wide range of disciplines, such as Cancer, Viral vector and CD40.
His study in Adenoviridae is interdisciplinary in nature, drawing from both Molecular biology, Receptor, Viral replication, Viral protein and Gene delivery. The Molecular biology study combines topics in areas such as Virus and Fas receptor. David T. Curiel works in the field of Virology, namely Oncolytic virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez.
Nature Medicine (2003)
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
Igor Dmitriev;Victor Krasnykh;C. Ryan Miller;Minghui Wang.
Journal of Virology (1998)
Adenovirus enhancement of transferrin-polylysine-mediated gene delivery.
David T. Curiel;Santosh Agarwal;Ernst Wagner;Matt Cotten.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Engineering targeted viral vectors for gene therapy
Reinhard Waehler;Stephen J. Russell;David T. Curiel.
Nature Reviews Genetics (2007)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.
Weiping Zou;Weiping Zou;Véronique Machelon;Aurore Coulomb-L'Hermin;Jozef Borvak.
Nature Medicine (2001)
Corneal avascularity is due to soluble VEGF receptor-1
Balamurali K. Ambati;Miho Nozaki;Nirbhai Singh;Atsunobu Takeda.
Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.
Ernst Wagner;Kurt Zatloukal;Matt Cotten;Helen Kirlappos.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
Chiba I;Takahashi T;Nau Mm;D'Amico D.
Replicative adenoviruses for cancer therapy.
Ramon Alemany;Cristina Balagué;David T. Curiel.
Nature Biotechnology (2000)
Targeted gene delivery by tropism-modified adenoviral vectors
Joanne T. Douglas;Buck E. Rogers;Maryland E. Rosenfeld;Sharon I. Michael.
Nature Biotechnology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: